Cargando…
Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer
FGF1 is an autocrine/paracrine regulator whose binding to heparan sulfate proteoglycans effectively precludes its circulation (1,2). Though known as a mitogenic factor, FGF1 knockout mice develop insulin resistance when stressed by a high fat diet, suggesting a potential role in nutrient homeostasis...
Autores principales: | Suh, Jae Myoung, Jonker, Johan W., Ahmadian, Maryam, Goetz, Regina, Lackey, Denise, Osborn, Olivia, Huang, Zifeng, Liu, Weilin, Yoshihara, Eiji, van Dijk, Theo, Havinga, Rick, Fan, Weiwei, Yin, Yun-Qiang, Yu, Ruth T., Liddle, Christopher, Atkins, Annette R., Olefsky, Jerrold M., Mohammadi, Moosa, Downes, Michael, Evans, Ronald M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184286/ https://www.ncbi.nlm.nih.gov/pubmed/25043058 http://dx.doi.org/10.1038/nature13540 |
Ejemplares similares
-
A PPARγ-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis
por: Jonker, Johan W., et al.
Publicado: (2012) -
The Pathologic Effect of a Novel Neomorphic Fgf9(Y162C) Allele Is Restricted to Decreased Vision and Retarded Lens Growth
por: Puk, Oliver, et al.
Publicado: (2011) -
UBE2G1 governs the destruction of cereblon neomorphic substrates
por: Lu, Gang, et al.
Publicado: (2018) -
Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases
por: Zhao, Longwei, et al.
Publicado: (2019) -
Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies
por: Ip, Carman K. M., et al.
Publicado: (2018)